How will $41 million be used to fight chronic and age-related diseases?
Drug Discovery World
NOVEMBER 16, 2022
Juvena Therapeutics, a biotechnology company scaling a computational platform to map the therapeutic potential of secreted proteins, has raised $41 million in an oversubscribed Series A, bringing its total funding to $50 million. This platform is applicable across a wide scope of disease indications.
Let's personalize your content